Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has announced the closure of its trading window for insiders, including designated persons and their immediate relatives, starting October 1, 2025. The window will remain shut until 48 hours after the company declares its unaudited standalone and consolidated financial results for Q2 and the half-year ended September 30, 2025. This is a standard regulatory practice under SEBI's Insider Trading Regulations and the company's internal code of conduct. It prevents insiders from trading in the stock while they may have access to unpublished financial information. No financial figures or operational details were disclosed in this filing.
This is a routine compliance announcement with no direct impact on shareholders or the stock price. Investors should note that upcoming Q2 results could be a catalyst for the stock once the trading window reopens.